Cargando…
Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome
AIM: To establish if serial Hepascore tests (referred to as delta Hepascore) in those with chronic hepatitis C (CHC) correlate with the increase and/or decrease in risk of liver related complications. METHODS: Three hundred and forty-six CHC patients who had two Hepascore tests performed were studie...
Autores principales: | Jeffrey, Angus W, Huang, Yi, de Boer, W Bastiaan, Adams, Leon A, MacQuillan, Gerry, Speers, David, Joseph, John, Jeffrey, Gary P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504360/ https://www.ncbi.nlm.nih.gov/pubmed/28740596 http://dx.doi.org/10.4254/wjh.v9.i19.850 |
Ejemplares similares
-
Effect of airplane transport of donor livers on post-liver transplantation survival
por: Huang, Yi, et al.
Publicado: (2016) -
Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Bertot, Luis C., et al.
Publicado: (2023) -
Hepascore predicts liver outcomes and all‐cause mortality in long‐term methotrexate users: A retrospective cohort study
por: Wang, Zhengyi, et al.
Publicado: (2020) -
Missed opportunities for hepatitis C treatment at a tertiary care hospital in South Australia
por: Raja, Sreecanth Sibhi, et al.
Publicado: (2022) -
Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
por: Tan, You-Wen, et al.
Publicado: (2023)